This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Dysplastic lesion of the vagina of unknown severity
N14_VAGINAL_DYSPLASIA_NOS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
38 |
4. Check minimum number of eventsNone |
38 |
5. Include endpointsNone |
38 |
6. Filter based on genotype QC (FinnGen only) |
38 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Dysplastic lesion of the vagina of unknown severity
based on the number of shared cases.
Similar with more cases:
- Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva
- All dysplastic lesions of the vagina
- Other noninflammatory disorders of vagina
- All dysplastic lesions of the cervix uteri, vagina or vulva
- Noninflammatory disorders of female genital tract
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 209 | 209 | - |
| Only index persons | 204 | 204 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | - |
| Only index persons | 0.01 | 0.01 | - |
| Median age at first event (years) | |||
| Whole population | - | 56.19 | - |
| Only index persons | - | 55.04 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 38 | 38 | - |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | - |
| Median age at first event (years) | 53.42 | 53.42 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
15
3.67
1.57
1.2
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
23
2.90
1.43
3.3
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
31
2.53
1.18
1.3
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
87
1.96
1.06
2.4
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
0
30
0.00
1.02
0.0
4.0
—
87.9
—
0
25
(3023368) Bacteria identified in Blood by Culture
13
84
1.83
0.86
3.2
4.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
6
32
2.03
0.86
1.2
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
25
2.15
0.76
1.0
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
48
1.84
0.68
1.3
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
0
19
0.00
0.62
0.0
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
7
107
0.58
0.60
2.3
1.7
mmol/l
1.2
1.3
—
7
92
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
6
39
1.64
0.56
2.0
4.1
ug/l
3.8
5.8
—
6
33
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
16
122
1.54
0.55
2.5
3.6
ng/l
87.3
27.9
—
7
78
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
5
83
0.54
0.53
5.8
2.9
ng/l
978.2
680.0
—
5
72
(3048689) Calprotectin [Mass/mass] in Stool
7
47
1.60
0.51
2.9
2.3
ug/g
528.6
188.3
—
7
38
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
7
50
1.49
0.48
2.1
2.7
%
34.2
22.7
—
7
41
(40768804) Tissue Pathology biopsy report
19
154
1.47
0.47
2.1
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
71
1.55
0.45
1.8
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
33
1.59
0.43
1.0
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
9
67
1.45
0.42
2.4
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
15
0.00
0.42
0.0
2.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.42
0.0
2.3
—
—
—
0
0
(3019225) pH of Specimen
5
34
1.54
0.42
2.0
3.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
18
0.00
0.41
0.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
0
18
0.00
0.41
0.0
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
6
89
0.61
0.38
1.2
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
14
111
1.41
0.37
2.8
3.4
u/l
23.5
29.2
0.97
14
106
(46235355) HIV 1 and 2 tests - Meaningful Use set
6
44
1.43
0.36
1.7
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
18
153
1.34
0.30
3.3
3.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
30
314
0.79
0.29
11.3
12.9
ml/min/173m2
83.1
80.8
0.27
23
247
(3011397) Hemoglobin [Presence] in Urine by Test strip
6
79
0.71
0.27
3.2
3.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
6
84
0.66
0.27
3.7
3.1
umol/l
313.7
6687.5
—
6
71
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
29
268
1.35
0.24
4.7
4.7
pmol/l
15.1
14.7
0.48
29
240
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
9
109
0.77
0.24
1.7
1.9
u/l
194.7
135.8
—
9
104
(3007853) Bacteria identified in Skin by Aerobe culture
5
39
1.32
0.24
1.4
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5
40
1.29
0.23
1.2
5.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
12
99
1.31
0.23
2.4
1.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
11
0.00
0.22
0.0
2.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
11
0.00
0.22
0.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
6
48
1.30
0.21
2.2
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(4034850)
0
13
0.00
0.21
0.0
6.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
0.2
—
0
13
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
7
84
0.80
0.16
3.4
1.9
mg/l
2.1
3.3
—
7
74
(3031040) Bacteria [#/volume] in Urine by Automated count
21
228
0.82
0.16
6.1
4.9
—
549.7
—
0
7
(3037467) Urinalysis macro (dipstick) panel - Urine
21
227
0.83
0.14
5.7
4.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
11
125
0.83
0.12
6.6
4.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
6
70
0.83
0.08
3.0
3.1
e6/l
7.3
5.2
—
6
61
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
15
138
1.14
0.08
2.3
1.9
pmol/l
75.5
103.8
—
6
70
(3041096) Erythrocytes [Presence] in Urine by Automated
9
86
1.06
0.08
6.7
3.8
—
—
—
0
0
(3013512) EKG study
9
101
0.86
0.07
3.4
3.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
29
282
1.12
0.07
15.4
18.0
g/l
331.0
330.0
0.27
29
282
(3026008) Bacteria identified in Urine by Culture
10
110
0.88
0.06
6.9
3.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
16
150
1.12
0.05
4.2
3.1
ug/l
139.2
80.8
0.37
16
139
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
11
119
0.89
0.04
3.2
3.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
11
102
1.11
0.03
2.6
7.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
23
236
0.94
0.01
3.6
2.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
11
111
0.99
0.00
2.7
2.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
11
109
1.01
0.00
6.0
5.6
—
—
—
0
0
(3015736) pH of Urine
13
135
0.94
0.00
4.6
3.8
—
—
—
0
0
(3044889) 12 lead EKG panel
23
233
0.97
0.00
3.7
3.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
10.4
—
0
6
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
2.0
—
133.0
—
0
6
(3011288) Drugs identified in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4281824)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4306422)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
0
6
0.00
0.00
0.0
6.7
—
2.8
—
0
6
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
6
0.00
0.00
0.0
1.8
—
108.8
—
0
6
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.5
—
0
5
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
101.8
—
0
5
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
9
96
0.92
0.00
3.4
2.8
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
234.8
—
0
5
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
5
0.00
0.00
0.0
2.2
—
7.6
—
0
5
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4094501)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
24.9
—
0
5
(3023420) DNA double strand Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
5
0.00
0.00
0.0
5.2
—
68.4
—
0
5
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
9
0.00
0.00
0.0
7.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8
78
1.03
0.00
3.1
5.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4268621)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint N14_VAGINAL_DYSPLASIA_NOS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have N14_VAGINAL_DYSPLASIA_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: N14_VAGINAL_DYSPLASIA_NOS – Dysplastic lesion of the vagina of unknown severity
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data